Molecular Recognition of Breast Cancer Biomarkers via Localized Surface Plasmon Resonance Method
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Advanced Biosensing Techniques and Applications · Advanced biosensing and bioanalysis techniques · Monoclonal and Polyclonal Antibodies Research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (100+)
Show source-provided references
1. R.L. Siegel, A.N. Giaquinto, A. Jemal, Cancer statistics, 2024, CA: a cancer journal for clinicians 74(1) (2024).10.3322/caac.21820 ↗
2. K. Nejati, S.F. Aval, M. Alivand, A. Akbarzadeh, A. Arabzadeh, Prominent prognostic factors in aggressive breast cancer: a review, International Journal of Cancer Management 14(9) (2021).10.5812/ijcm.109015 ↗
3. Barclay NL, Burn E, Delmestri A, Duarte-Salles T, Golozar A, Man WY, Tan EH, Tietzova I, Prieto-Alhambra D (2024) Trends in incidence, prevalence, and survival of breast cancer in the United Kingdom from 2000 to 2021. Sci Rep 14(1):1906910.1038/s41598-024-69006-1 ↗
4. C. Lino, S. Barrias, R. Chaves, F. Adega, P. Martins-Lopes, J. Fernandes, Biosensors as diagnostic tools in clinical applications, Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1877(3) (2022) 188726.10.1016/j.bbcan.2022.188726 ↗
5. O. Yeganeh, E.D. Abdolahinia, S.R. Soofiyani, E. Faghfuri, A. Shafie, Y. Pahlavan, Biosensors for autoimmune diseases, Clinica Chimica Acta (2024) 119998.10.1016/j.cca.2024.119998 ↗
6. Pahlavan Y, Kahroba H, Samadi N, Karimi A, Ansarin K, Khabbazi A (2019) Survivin modulatory role in autoimmune and autoinflammatory diseases. J Cell Physiol 234(11):19440–1945010.1002/jcp.28725 ↗
7. Pahlavan Y, Samadi N, Ansarin K, Khabbazi A (2020) Phosphorylation modulates survivin function in Behcet’s disease. Advanced Pharmaceutical Bulletin 10(2):27810.34172/apb.2020.033 ↗
8. Wahab MRA, Palaniyandi T, Viswanathan S, Baskar G, Surendran H, Gangadharan S, Sugumaran A, Sivaji A, Kaliamoorthy S, Kumarasamy S (2024) Biomarker-specific biosensors revolutionise breast cancer diagnosis. Clin Chim Acta 555:11779210.1016/j.cca.2024.117792 ↗
9. Monirinasab H, Zakariazadeh M, Kohestani H, Kouhestani M, Fathi F (2022) Study of β-lactam-based drug interaction with albumin protein using optical, sensing, and docking methods. J Biol Phys 48(2):177–19410.1007/s10867-021-09599-0 ↗
10. Ranjbari F, Nosrat A, Fathi F, Mohammadzadeh A (2024) Surface plasmon resonance biosensors for early troponin detection, Clinica Chimica Acta 118670.10.1016/j.cca.2024.118670 ↗
11. Fathi F, Rezabakhsh A, Rahbarghazi R, Rashidi M-R (2017) Early-stage detection of VE-cadherin during endothelial differentiation of human mesenchymal stem cells using SPR biosensor. Biosens Bioelectron 96:358–36610.1016/j.bios.2017.05.018 ↗
12. Liu D (2019) Cancer biomarkers for targeted therapy. Biomarker research 7(1):2510.1186/s40364-019-0178-7 ↗
13. Amgad M, Hodge JM, Elsebaie MA, Bodelon C, Puvanesarajah S, Gutman DA, Siziopikou KP, Goldstein JA, Gaudet MM, Teras LR (2024) A population-level digital histologic biomarker for enhanced prognosis of invasive breast cancer. Nat Med 30(1):85–9710.1038/s41591-023-02643-7 ↗
14. Fusco N, Malapelle U, Criscitiello C (2023) Diagnosis and treatment of breast cancer in 2022: the rise of novel molecular biomarkers. Front Mol Biosci 9:111732310.3389/fmolb.2022.1117323 ↗
15. Pahlavan Y, Nasr MM, Abdolahinia ED, Pirdel Z, Soofiyani SR, Siahpoush S, Nejati K (2020) Prominent roles of microRNA-142 in cancer. Pathology-Research and Practice 216(11):15322010.1016/j.prp.2020.153220 ↗
16. Nejati K, Alivand M, Arabzadeh A (2021) MicroRNA-22 in female malignancies: focusing on breast, cervical, and ovarian cancers. Pathology-Research and Practice 223:15345210.1016/j.prp.2021.153452 ↗
17. Zhou Z, Zou L, Guan Y, Jiang L, Liu Y, Zhang X, Huang X, Ren H, Li Z, Niu H (2024) Survivin as a potential biomarker in the diagnosis of bladder cancer: a systematic review and meta-analysis, Urologic Oncology: Seminars and Original Investigations, Elsevier10.1016/j.urolonc.2024.01.018 ↗
18. Uniyal A, Srivastava G, Pal A, Taya S, Muduli A (2023) Recent advances in optical biosensors for sensing applications: a review. Plasmonics 18(2):735–75010.1007/s11468-023-01803-2 ↗
19. Marghani BH, Fehaid A, Ateya AI, Ezz MA, Saleh RM (2022) Photothermal therapeutic potency of plasmonic silver nanoparticles for apoptosis and anti-angiogenesis in testosterone induced benign prostate hyperplasia in rats. Life Sci 291:12024010.1016/j.lfs.2021.120240 ↗
20. Reddy PJ, Sadhu S, Ray S, Srivastava S (2012) Cancer biomarker detection by surface plasmon resonance biosensors. Clin Lab Med 32(1):47–7210.1016/j.cll.2011.11.002 ↗
21. Phiri IK, Zekriti M (2024) Sensitivity and performance enhancement of an SPR biosensor using a gold-silver alloy, zinc oxide and graphene. Opt Quant Electron 56(8):133210.1007/s11082-024-07227-4 ↗
22. Azzouz A, Hejji L, Kim K-H, Kukkar D, Souhail B, Bhardwaj N, Brown RJ, Zhang W (2022) Advances in surface plasmon resonance–based biosensor technologies for cancer biomarker detection. Biosens Bioelectron 197:11376710.1016/j.bios.2021.113767 ↗
23. Dadkhah M, Jafarzadehgharehziaaddin M, Molaei S, Akbari M, Gholizadeh N, Fathi F (2023) Major depressive disorder: biomarkers and biosensors. Clin Chim Acta 547:11743710.1016/j.cca.2023.117437 ↗
24. F. Ranjbari, F. Fathi, Recent advances in chemistry, mechanism, and applications of quantum dots in photodynamic and photothermal therapy, Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry-Anti-Cancer Agents) 24(10) (2024) 733–744.10.2174/0118715206295598240215112910 ↗
25. Cuthrell KM, Tzenios N (2023) Breast cancer: updated and deep insights, International Research. Journal of Oncology 6(1):104–118
26. Hasan MM, Mohanan P, Bibi S, Babu C, Roy YJ, Mathews A, Khatri G, Papadakos SP (2023) Radiotherapy in breast cancer, Springer10.1007/16833_2023_176 ↗
27. Ranjbari F, Hemmati S, Rashidi MR (2021) Synthesis of 7, 12-bis (4-(di (1H-pyrrol-2-yl) methyl) phenyl) benzo [k] fluoranthene from anew dialdehyde as a novel fluorometric bis-dipyrromethane derivative. Turk J Chem 45(1):42–4910.3906/kim-2004-72 ↗
28. Ferreira VG, Rossini EL, Araújo LX, Almeida MB, Carrilho E (2024) Biomarkers: an introduction, Biosensors in Precision Medicine, Elsevier pp. 3–34.10.1016/B978-0-443-15380-8.00001-1 ↗
29. Dadashpour M, Ganjibakhsh M, Mousazadeh H, Nejati K (2023) Increased pro-apoptotic and anti-proliferative activities of simvastatin encapsulated PCL-PEG nanoparticles on human breast cancer adenocarcinoma cells. J Cluster Sci 34(1):211–22210.1007/s10876-021-02217-y ↗
30. Ranjbari F, Rashidi MR, Hemmati S, Safari E, Tajalli H (2023) Synthesis of novel cationic photosensitizers derived from chlorin for application in photodynamic therapy of cancer. Curr Radiopharm 16(4):315–32510.2174/1874471016666230526153806 ↗
31. Clusan L, Ferrière F, Flouriot G, Pakdel F (2023) A basic review on estrogen receptor signaling pathways in breast cancer. Int J Mol Sci 24(7):683410.3390/ijms24076834 ↗
32. Fei F, Siegal GP, Wei S (2021) Characterization of estrogen receptor-low-positive breast cancer. Breast Cancer Res Treat 188:225–23510.1007/s10549-021-06148-0 ↗
33. Scabia V, Ayyanan A, De Martino F, Agnoletto A, Battista L, Laszlo C, Treboux A, Zaman K, Stravodimou A, Jallut D (2022) Estrogen receptor positive breast cancers have patient specific hormone sensitivities and rely on progesterone receptor. Nat Commun 13(1):312710.1038/s41467-022-30898-0 ↗
34. Farcas AM, Nagarajan S, Cosulich S, Carroll JS (2021) Genome-wide estrogen receptor activity in breast cancer. Endocrinology 162(2):bqaa22410.1210/endocr/bqaa224 ↗
35. Miziak P, Baran M, Błaszczak E, Przybyszewska-Podstawka A, Kałafut J, Smok-Kalwat J, Dmoszyńska-Graniczka M, Kiełbus M, Stepulak A (2023) Estrogen receptor signaling in breast cancer. Cancers 15(19):468910.3390/cancers15194689 ↗
36. Neves Rebello Alves L, Dummer Meira D, Poppe Merigueti L, Correia Casotti M, do Prado Ventorim D, Ferreira Figueiredo Almeida J, Pereira de Sousa V, Cindra Sant’Ana, Gonçalves Coutinho da Cruz R, Santos Louro L (2023) Markers in breast cancer: an old story with a new end. Genes 14(7) (2023) 136410.3390/genes14071364 ↗
37. Oubaddou Y, Ali FB, Oubaqui FE, Qmichou Z, Bakri Y, Ameziane RAR (2023) The tumor suppressor BRCA1/2, cancer susceptibility and genome instability in gynecological and mammary cancers. Asian Pacific Journal of Cancer Prevention: APJCP 24(9):313910.31557/APJCP.2023.24.9.3139 ↗
38. Dias Nunes J, Demeestere I, Devos M (2023) BRCA mutations and fertility preservation. International journal of molecular sciences 25(1):20410.3390/ijms25010204 ↗
39. Kavarthapu R, Anbazhagan R, Dufau ML (2021) Crosstalk between PRLR and EGFR/HER2 signaling pathways in breast cancer. Cancers 13(18):468510.3390/cancers13184685 ↗
40. Y. Pahlavan, A. Khabbazi, Baculoviral inhibitor of apoptosis family of proteins repeat-containing 5 gene methylation status in peripheral blood mononuclear cells and plasma survivin levels in patients with Behçet’s disease, Archives of Rheumatology 36(2) (2021).10.46497/ArchRheumatol.2021.8163 ↗
41. Lopez-Gonzalez L, Sanchez Cendra A, Sanchez Cendra C, Roberts Cervantes ED, Espinosa JC, Pekarek T, Fraile-Martinez O, García-Montero C, Rodriguez-Slocker AM, Jiménez-Álvarez L (2024) Exploring biomarkers in breast cancer: hallmarks of diagnosis, treatment, and follow-up in clinical practice. Medicina 60(1):16810.3390/medicina60010168 ↗
42. Rakha EA, Tan PH, Quinn C, Provenzano E, Shaaban AM, Deb R, Callagy G, Starczynski J, Lee AHS, Ellis IO (2023) UK recommendations for HER2 assessment in breast cancer: an update. J Clin Pathol 76(4):217–22710.1136/jcp-2022-208632 ↗
43. Marvalim C, Datta A, Lee SC (2023) Role of p53 in breast cancer progression: an insight into p53 targeted therapy. Theranostics 13(4):142110.7150/thno.81847 ↗
44. Mueller S, Grote I, Bartels S, Kandt L, Christgen H, Lehmann U, Gluz O, Graeser M, Kates R, Harbeck N (2023) p53 expression in luminal breast cancer correlates with TP53 mutation and primary endocrine resistance. Mod Pathol 36(4):10010010.1016/j.modpat.2023.100100 ↗
45. Chen X, Zhang T, Su W, Dou Z, Zhao D, Jin X, Lei H, Wang J, Xie X, Cheng B (2022) Mutant p53 in cancer: from molecular mechanism to therapeutic modulation. Cell Death Dis 13(11):97410.1038/s41419-022-05408-1 ↗
46. Shahbandi A, Nguyen HD, Jackson JG (2020) TP53 mutations and outcomes in breast cancer: reading beyond the headlines. Trends in cancer 6(2):98–11010.1016/j.trecan.2020.01.007 ↗
47. Abolghasemi M, Tehrani SS, Yousefi T, Karimian A, Mahmoodpoor A, Ghamari A, Jadidi-Niaragh F, Yousefi M, Kafil HS, Bastami M (2020) MicroRNAs in breast cancer: roles, functions, and mechanism of actions. J Cell Physiol 235(6):5008–502910.1002/jcp.29396 ↗
48. Yang Z, Liu Z (2020) The emerging role of microRNAs in breast cancer. Journal of Oncology 2020(1):9160905
49. Rama K, Bitla AR, Hulikal N, Yootla M, Yadagiri LA, Asha T, Manickavasagam M, Rao PS (2024) Assessment of serum microRNA-21 and miRNA-205 as diagnostic markers for stage I and II breast cancer in Indian population. Indian J Cancer 61(2):290–29810.4103/ijc.IJC_187_20 ↗
50. Łukasiewicz S, Czeczelewski M, Forma A, Baj J, Sitarz R, Stanisławek A (2021) Breast cancer—epidemiology, risk factors, classification, prognostic markers, and current treatment strategies—an updated review. Cancers 13(17):428710.3390/cancers13174287 ↗
51. Zhang D, Fang C, Li H, Lu C, Huang J, Pan J, Yang Z, Liang E, Liu Z, Zhou X (2021) Long ncRNA MALAT1 promotes cell proliferation, migration, and invasion in prostate cancer via sponging miR-145. Translational Andrology and Urology 10(6):230710.21037/tau-20-1526 ↗
52. Mani C, Reddy PH, Palle K (2020) DNA repair fidelity in stem cell maintenance, health, and disease, Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1866(4):16544410.1016/j.bbadis.2019.03.017 ↗
53. Bovaird S (2020) Defining the impact of genotoxic stress on post-transcriptional gene regulation and RNA localization pathways, McGill University (Canada)
54. Miklikova S, Trnkova L, Plava J, Bohac M, Kuniakova M, Cihova M (2021) The role of BRCA1/2-mutated tumor microenvironment in breast cancer. Cancers 13(3):57510.3390/cancers13030575 ↗
55. Coyle EA, Taj H, Comba I, Vasquez J, Zayat V (2020) Invasive micropapillary carcinoma: a rare case of male breast cancer, Cureus 12(9)10.7759/cureus.10571 ↗
56. Grossi I, Marchina E, De Petro G, Salvi A (2023) The biological role and translational implications of the long non-coding RNA GAS5 in breast cancer. Cancers 15(13):331810.3390/cancers15133318 ↗
57. Fusco N, Malapelle U, Fassan M, Marchiò C, Buglioni S, Zupo S, Criscitiello C, Vigneri P, Dei Tos AP, Maiorano E (2021) PIK3CA mutations as a molecular target for hormone receptor-positive, HER2-negative metastatic breast cancer. Frontiers in Oncology 11 64473710.3389/fonc.2021.644737 ↗
58. Rashidieh B, Molakarimi M, Mohseni A, Tria SM, Truong H, Srihari S, Adams RC, Jones M, Duijf PHG, Kalimutho M (2021) Targeting BRF2 in cancer using repurposed drugs. Cancers 13(15):377810.3390/cancers13153778 ↗
59. Rashidieh B, Molakarimi M, Mohseni A, Tria SM, Truong H, Srihari S, Adams RC, Jones M, Duijf PHG, Kalimutho M (2021) Targeting BRF2 in cancer using repurposed drugs. Cancers 2021, 13, 3778, s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2021.10.3390/cancers13153778 ↗
60. Ulaganathan K, Alipeddi RR, Hanumanth SR (2024) Identifying microRNA-target gene pairs in luminal B breast cancer using integrated analysis of miRNA and transcriptome profiles. Advances in Breast Cancer Research 13(4):69–10010.4236/abcr.2024.134008 ↗
61. Cerma K, Piacentini F, Moscetti L, Barbolini M, Canino F, Tornincasa A, Caggia F, Cerri S, Molinaro A, Dominici M (2023) Targeting PI3K/AKT/mTOR pathway in breast cancer: from biology to clinical challenges. Biomedicines 11(1):10910.3390/biomedicines11010109 ↗
62. Gautam SK, Khan P, Natarajan G, Atri P, Aithal A, Ganti AK, Batra SK, Nasser MW, Jain M (2023) Mucins as potential biomarkers for early detection of cancer. Cancers 15(6):164010.3390/cancers15061640 ↗
63. Miyazaki CM, Shimizu FM, Ferreira M (2017) Surface plasmon resonance (SPR) for sensors and biosensors. Elsevier, Nanocharacterization techniques, pp 183–200
64. Karki B, Uniyal A, Pal A, Srivastava V (2022) Advances in surface plasmon resonance-based biosensor technologies for cancer cell detection. International Journal of Optics 2022(1):147625410.1155/2022/1476254 ↗
65. Nguyen HH, Park J, Kang S, Kim M (2015) Surface plasmon resonance: a versatile technique for biosensor applications. Sensors 15(5):10481–1051010.3390/s150510481 ↗
66. Fathi F, Monirinasab H, Ranjbary F, Nejati-Koshki K (2022) Inverse opal photonic crystals: Recent advances in fabrication methods and biological applications. Journal of Drug Delivery Science and Technology 72:10337710.1016/j.jddst.2022.103377 ↗
67. Lopez Baltazar JM, Gu W, Bocková M, Yu Q (2024) Immunoassays for extracellular vesicle detection via transmembrane proteins using surface plasmon resonance biosensors, ACS sensors 9(7)3594–360310.1021/acssensors.4c00558 ↗
68. Nejati-Koshki K, Fathi F, Arabzadeh A, Mohammadzadeh A (2023) Biomarkers and optical based biosensors in cardiac disease detection: early and accurate diagnosis. Anal Methods 15(41):5441–545810.1039/D3AY01414B ↗
69. Maleki S, Arabzadeh A, Nejati K, Fathi F (2021) Exploring the interactions of a natural gamma-oryzanol with human serum albumin: surface plasmon resonance, fluorescence, and molecular modeling studies. Drug Research 71(09):520–52710.1055/a-1533-2941 ↗
70. J. Homola, M. Piliarik, Surface plasmon resonance (SPR) sensors, Springer2006.10.1007/b100321 ↗
71. Fathi F, Chaghamirzaei P, Allahveisi S, Ahmadi-Kandjani S, Rashidi M-R (2021) Investigation of optical and physical property in opal films prepared by colloidal and freeze-dried microspheres. Colloids Surf, A 611:12584210.1016/j.colsurfa.2020.125842 ↗
72. Lakayan D, Tuppurainen J, Albers M, van Lint MJ, van Iperen DJ, Weda JJ, Kuncova-Kallio J, Somsen GW, Kool J (2018) Angular scanning and variable wavelength surface plasmon resonance allowing free sensor surface selection for optimum material-and bio-sensing. Sens Actuators, B Chem 259:972–97910.1016/j.snb.2017.12.131 ↗
73. Löfås S, Malmqvist M, Rönnberg I, Stenberg E, Liedberg B, Lundström I (1991) Bioanalysis with surface plasmon resonance. Sens Actuators, B Chem 5(1–4):79–8410.1016/0925-4005(91)80224-8 ↗
74. Fathi F, Jalili R, Amjadi M, Rashidi M-R (2018) SPR signals enhancement by gold nanorods for cell surface marker detection, BioImpacts: BI 9(2):7110.15171/bi.2019.10 ↗
75. Uniyal A, Chauhan B, Pal A, Singh Y (2022) Surface plasmon biosensor based on Bi 2 Te 3 antimonene heterostructure for the detection of cancer cells. Appl Opt 61(13):3711–371910.1364/AO.454789 ↗
76. Piliarik M, Homola J (2009) Surface plasmon resonance (SPR) sensors: approaching their limits? Opt Express 17(19):16505–1651710.1364/OE.17.016505 ↗
77. Ma X, Xu X, Zheng Z, Wang K, Su Y, Fan J, Zhang R, Song L, Wang Z, Zhu J (2010) Dynamically modulated intensity interrogation scheme using waveguide coupled surface plasmon resonance sensors. Sens Actuators, A 157(1):9–1410.1016/j.sna.2009.11.004 ↗
78. Kumar V, Raghuwanshi SK, Kumar S (2024) Advances in SPR-based fiber optic sensors for voltage/electric field measurement–a review, IEEE Sensors Journal.10.1109/JSEN.2024.3373389 ↗
79. Zhou J, Qi Q, Wang C, Qian Y, Liu G, Wang Y, Fu L (2019) Surface plasmon resonance (SPR) biosensors for food allergen detection in food matrices. Biosens Bioelectron 142:11144910.1016/j.bios.2019.111449 ↗
80. Zhang J, Sun Y, Wu Q, Gao Y, Zhang H, Bai Y, Song D (2014) Preparation of graphene oxide-based surface plasmon resonance biosensor with Au bipyramid nanoparticles as sensitivity enhancer. Colloids Surf, B 116:211–21810.1016/j.colsurfb.2014.01.003 ↗
81. Zhou Y, Liu H, Xia J, Zhu Z, Koh K, Chen H (2024) Controllable synthesis of multi-tip spatial gold nanostructures to facilitate SPR enhancement for exosomal PD-L1 assay. Chem Eng J 481:14813710.1016/j.cej.2023.148137 ↗
82. Xu Y, Bai P, Zhou X, Akimov Y, Png CE, Ang LK, Knoll W, Wu L (2019) Optical refractive index sensors with plasmonic and photonic structures: promising and inconvenient truth. Advanced Optical Materials 7(9):180143310.1002/adom.201801433 ↗
83. Vasić B, Isić G, Gajić R (2013) Localized surface plasmon resonances in graphene ribbon arrays for sensing of dielectric environment at infrared frequencies. J Appl Phys 113(1)10.1063/1.4773474 ↗
84. Nangare SN, Patil PO (2020) Affinity-based nanoarchitectured biotransducer for sensitivity enhancement of surface plasmon resonance sensors for in vitro diagnosis: a review. ACS Biomater Sci Eng 7(1):2–3010.1021/acsbiomaterials.0c01203 ↗
85. Schuck P, Zhao H (2010) The role of mass transport limitation and surface heterogeneity in the biophysical characterization of macromolecular binding processes by SPR biosensing, Surface plasmon resonance: methods and protocols 15–5410.1007/978-1-60761-670-2_2 ↗
86. Richalet-Sécordel PM, Rauffer-Bruyère N, Christensen LL, Ofenloch-Haehnle B, Seidel C, Van Regenmortel MH (1997) Concentration measurement of unpurified proteins using biosensor technology under conditions of partial mass transport limitation. Anal Biochem 249(2):165–17310.1006/abio.1997.2183 ↗
87. Karki B, Uniyal A, Sharma M, Yadav RB, Buduma P (2024) Tuning sensitivity of bimetallic, MXene and graphene-based SPR biosensors for rapid malaria detection: a numerical approach. J Comput Electron 1–10.10.1007/s10825-024-02191-4 ↗
88. Bellassai N, D’Agata R, Jungbluth V, Spoto G (2019) Surface plasmon resonance for biomarker detection: advances in non-invasive cancer diagnosis. Front Chem 7:57010.3389/fchem.2019.00570 ↗
89. Haghaei H, Hosseini SRA, Soltani S, Fathi F, Mokhtari F, Karima S, Rashidi M-R (2019) Kinetic and thermodynamic study of beta-Boswellic acid interaction with Tau protein investigated by surface plasmon resonance and molecular modeling methods, BioImpacts: BI 10(1)1710.15171/bi.2020.03 ↗
90. Herrera ND, Esteban O, Navarrete M-C, González-Cano A, Benito-Pena E, Orellana G (2011) Improved performance of SPR sensors by a chemical etching of tapered optical fibers. Opt Lasers Eng 49(8):1065–106810.1016/j.optlaseng.2011.03.012 ↗
91. Singh S, Prajapati Y (2021) Highly sensitive dual-core symmetrical side-polished modified D-shaped SPR based PCF refractive index sensor with deeply etched micro openings. Optik 235:16665710.1016/j.ijleo.2021.166657 ↗
92. Bae S-W, Kim H-M, Park J-H, Lee S-K (2019) Improvement of fiber optic based localized surface plasmon resonance sensor by optical fiber surface etching and Au capping. Micro and Nano Systems Letters 7:1–710.1186/s40486-019-0080-y ↗
93. Yu X, Xu D, Cheng Q (2006) Label-free detection methods for protein microarrays. Proteomics 6(20):5493–550310.1002/pmic.200600216 ↗
94. Guner H, Ozgur E, Kokturk G, Celik M, Esen E, Topal AE, Ayas S, Uludag Y, Elbuken C, Dana A (2017) A smartphone based surface plasmon resonance imaging (SPRi) platform for on-site biodetection. Sens Actuators, B Chem 239:571–57710.1016/j.snb.2016.08.061 ↗
95. Peterson AW, Halter M, Tona A, Plant AL (2014) High resolution surface plasmon resonance imaging for single cells. BMC Cell Biol 15:1–1410.1186/1471-2121-15-35 ↗
96. Rivera V, Ferri F, Marega E Jr (2012) Localized surface plasmon resonances: noble metal nanoparticle interaction with rare-earth ions. Plasmonics-Principles and Applications 1(11):283–312
97. Karki B, Pal A, Sarkar P, Yadav RB, Muduli A, Trabelsi Y (2024) ZnO-silicon enhanced surface plasmon resonance sensor for chemical sensing. Silicon 1–1210.1007/s12633-024-02973-2 ↗
98. Singh P (2016) LSPR biosensing: recent advances and approaches. Reviews in Plasmonics 2017:211–238
99. Zhou J, Wang Y, Zhang L, Li X (2018) Plasmonic biosensing based on non-noble-metal materials. Chin Chem Lett 29(1):54–6010.1016/j.cclet.2017.09.003 ↗
100. Yüce M, Kurt H (2017) How to make nanobiosensors: surface modification and characterisation of nanomaterials for biosensing applications. RSC Adv 7(78):49386–4940310.1039/C7RA10479K ↗